Metformin use and the Risk of Gastrointestinal Malignancies in Diabetic Populations: A Meta-Analysis
<p>Background: Metformin use has been associated with a decreased risk of cancer and improvement in overall cancer survival rates. However, scant data available regarding metformin's role in the risk of Gastrointestinal (GI) malignancies in patients with type II diabetes. Our study aimed...
Saved in:
Main Authors: | Gil Hevroni (Author), Samara Skwiersky (Author), Angelina Zhyvotovska (Author), Samy I McFarlane (Author) |
---|---|
Format: | Book |
Published: |
International Journal of Clinical Endocrinology and Metabolism - Peertechz Publications,
2020-12-26.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Obesity, Diabetes and Gastrointestinal Malignancy: The role of Metformin and other Anti-diabetic Therapy
by: Michael Ashamalla, et al.
Published: (2018) -
Gastrointestinal Malignancies: Screening, Diagnosis, and Treatment
Published: (2023) -
Multimodal Therapy of Upper Gastrointestinal Malignancies
Published: (2021) -
Diabetic Retinopathy: Focus on Minority Populations
by: Arpine Barsegian, et al.
Published: (2017) -
Metformin: Beyond Diabetes
Published: (2020)